Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women

被引：7

作者：

Ibanez, Lourdes ^{[1
]}

de Zegher, Francis

机构：

[1] Univ Barcelona, Hosp St Joan Deu, Endocrinol Unit, Barcelona, Spain

[2] Katholieke Univ Leuven, Dept Woman & Child, Louvain, Belgium

来源：

FERTILITY AND STERILITY | 2006年 / 86卷

关键词：

body composition; hyperinsulinemic hyperandrogenism; hyperinsulinemia;

D O I：

10.1016/j.fertnstert.2006.03.006

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Hyperinsulinemic hyperandrogenism is the core of polycystic ovary syndrome (PCOS), and accordingly low-dose flutamide-metformin proved so far to be a most effective approach to normalize the broad spectrum of PCOS anomalies in nonobese adolescents and young women. For safety reasons, it is wise to combine flutamide-metformin with a contraceptive, for example, an oral or transdermal estroprogestagen.

引用

页码：S24 / S25

页数：2

共 50 条

[1] Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women
Ibáñez, L
de Zegher, F
HUMAN REPRODUCTION UPDATE, 2006, 12 (03) : 243 - 252
[2] Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism
Ibáñez, L
Ong, K
Ferrer, A
Amin, R
Dunger, D
de Zegher, F
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06): : 2600 - 2606
[3] Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism:: Effects in adolescents and in women on third-generation oral contraception
Ibáñez, L
de Zegher, F
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10): : 4720 - 4724
[4] Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism:: Opposite effects on adipocytokines and body adiposity
Ibáñez, L
de Zegher, F
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04): : 1592 - 1597
[5] Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism:: The key role of early, low-dose flutamide
Ibáñez, L
Valls, C
Cabré, S
de Zegher, F
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09): : 4716 - 4720
[6] Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism:: normalizing effects on CRP, TNF-α and the neutrophil/lymphocyte ratio
Ibáñez, L
Valls, C
de Zegher, F
HUMAN REPRODUCTION, 2006, 21 (02) : 451 - 456
[7] Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess
Ibanez, Lourdes
Lopez-Bermejo, Abel
del Rio, Luis
Enriquez, Goya
Valls, Carme
de Zegher, Francis
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (05): : 1710 - 1714
[8] Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism:: The key role of metformin at the start and after more than one year of therapy
Ibáñez, L
de Zegher, F
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01): : 39 - 43
[9] Very low dose of flutamide in the treatment of hyperandrogenism
Fulghesu, Anna Maria
Melis, Federica
Murru, Giulia
Canu, Elena
Melis, Gian Benedetto
GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (05) : 394 - 398
[10] THERAPY Low-dose flutamide for hirsutism: into the limelight, at last
de Zegher, Francis
Ibanez, Lourdes
NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (08) : 421 - 422

← 1 2 3 4 5 →